SLC3A2 and prostate cancer: Proteomic analysis of microvesicles secreted by prostate cancer cells revealed a high content of cytoskeletal proteins, including the heavy chain of dynein, suggesting a potential avenue for the clinical detection of aberrantly expressed vesicular trafficking machinery that may inform on prostate cancer prognosis [196].